Antineoplastic Combined Chemotherapy ProtocolsLigandsLegg-Calve-Perthes DiseaseApoptosisAntineoplastic AgentsApoptosis Regulatory ProteinsCaspasesCaspase 3CisplatinCombined Modality TherapyProto-Oncogene Proteins c-bcl-2DoxorubicinFas Ligand ProteinCell Line, TumorInhibitor of Apoptosis ProteinsCyclophosphamideSignal TransductionTreatment OutcomeTime FactorsEtoposideBreast NeoplasmsCell SurvivalDNA Fragmentationbcl-2-Associated X ProteinIn Situ Nick-End LabelingCells, CulturedNeoadjuvant TherapyX-Linked Inhibitor of Apoptosis ProteinDose-Response Relationship, DrugTumor Cells, CulturedDisease-Free SurvivalLung NeoplasmsCD40 LigandNeoplasm StagingTumor Suppressor Protein p53Cell LineDrug Resistance, NeoplasmSurvival AnalysisCASP8 and FADD-Like Apoptosis Regulating ProteinApoptosis Inducing FactorCaspase 9Enzyme ActivationPrognosisCaspase InhibitorsPhotic StimulationCell ProliferationSurvival RateCaspase 8PaclitaxelNeoplasmsDrug Administration ScheduleFlow CytometryMitochondriaTNF-Related Apoptosis-Inducing LigandAntineoplastic Agents, PhytogenicBlotting, WesternMethotrexateMembrane GlycoproteinsCarboplatinbcl-X ProteinCytochromes cTransfectionProto-Oncogene ProteinsVinblastineProtein BindingMice, Inbred C57BLRNA, MessengerTaxoidsInduction ChemotherapyAnnexin A5Enzyme InhibitorsCell CycleAntimetabolites, AntineoplasticImmunohistochemistryNeoplasm Recurrence, LocalMolecular Sequence DataCell DivisionBleomycinRecombinant ProteinsCysteine Proteinase InhibitorsNeurobehavioral ManifestationsOrganoplatinum CompoundsIfosfamidePhosphorylationAntibiotics, AntineoplasticDown-RegulationReverse Transcriptase Polymerase Chain ReactionAdenocarcinomaTumor Necrosis Factor-alphaOvarian NeoplasmsAmino Acid Chloromethyl KetonesRNA, Small InterferingPoly(ADP-ribose) PolymerasesJurkat CellsGene Expression Regulation, NeoplasticUp-RegulationAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungModels, BiologicalGeneralization, Stimulus